CorMedix announces $128.6 million of net revenue for the fourth quarter of 2025, largely driven by continued utilization of DefenCath by its outpatient dialysis customers. DefenCath sales contributed ...

Q4 2025 Net Revenue of $128.6 million - Pro Forma Full Year 2025 Net Revenue of $401.3 million - Q4 2025 Net Income of $14.0 million; Adjusted EBITDA of $77.2 million - Conference Call Scheduled for ...

Investor Day presentation scheduled for June 3, 2026, in Phoenix, Arizona, during which management will provide details on its value creation strategy and financial outlook ...

German borrower has repaid full principal amount of $5.0M, plus interest and expense reimbursement of $1.4MTRNR ...

India's insurance regulator, IRDAI, is proposing a significant shift in financial reporting for all insurers. Starting April ...

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript March 5, 2026 REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.3 EPS, expectations were $-1.01. Operator: Thank you for ...

Canada Packers Inc. ("Canada Packers" or the "Company") (TSX: CPKR) today reported its financial results for the fiscal year ...

Detailed price information for Global Payments Inc (GPN-N) from The Globe and Mail including charting and trades.

As previously announced, Xanadu is advancing its business combination with Crane Harbor and a newly formed public company, Xanadu Quan ...

The Securities and Exchange Commission has reached a partial settlement with a consultant who prepared financial projections supporting a municipal bond offering for an ill-fated Arizona sports ...

Cross Country Healthcare, Inc. (the "Company," "Cross Country," "we," "us," and "our") (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025.

Seaport Entertainment Group Inc. (NYSE:SEG) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Greetings, and welcome to the Seaport Entertainment Group Inc. Fourth Quarter and Full Year 2025 ...